hlb sofjec fda
Scope
Date
~
-
Bio & PharmaKorea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
COVID-19Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
BiosimilarsSamsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Short sellingRetail investors test Celltrion, HLB shares as Korea’s GameStop
Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...
Feb 01, 2021 (Gmt+09:00)
-
RoboticsKorea's first neurosurgery robot to debut; to seek FDA approval
Koh Young Technology Inc., a 3D inspection device maker in South Korea, has commercialized a neurosurgical robotics system for the second time in the ...
Jun 22, 2020 (Gmt+09:00)
